SURGE COPPER CORP (SURG.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:SURG • CA86881M1041

0.55 CAD
-0.05 (-8.33%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

2

Overall SURG gets a fundamental rating of 2 out of 10. We evaluated SURG against 814 industry peers in the Metals & Mining industry. The financial health of SURG is average, but there are quite some concerns on its profitability. SURG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • SURG had negative earnings in the past year.
  • SURG had a negative operating cash flow in the past year.
  • SURG had negative earnings in each of the past 5 years.
  • SURG had a negative operating cash flow in each of the past 5 years.
SURG.CA Yearly Net Income VS EBIT VS OCF VS FCFSURG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • SURG has a Return On Assets of -3.76%. This is in the better half of the industry: SURG outperforms 74.82% of its industry peers.
  • With a decent Return On Equity value of -4.12%, SURG is doing good in the industry, outperforming 77.03% of the companies in the same industry.
Industry RankSector Rank
ROA -3.76%
ROE -4.12%
ROIC N/A
ROA(3y)-3.72%
ROA(5y)-7.73%
ROE(3y)-4.12%
ROE(5y)-8.46%
ROIC(3y)N/A
ROIC(5y)N/A
SURG.CA Yearly ROA, ROE, ROICSURG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SURG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SURG.CA Yearly Profit, Operating, Gross MarginsSURG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

5

2. Health

2.1 Basic Checks

  • SURG has more shares outstanding than it did 1 year ago.
  • SURG has more shares outstanding than it did 5 years ago.
  • SURG has a better debt/assets ratio than last year.
SURG.CA Yearly Shares OutstandingSURG.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SURG.CA Yearly Total Debt VS Total AssetsSURG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

  • SURG has an Altman-Z score of 18.18. This indicates that SURG is financially healthy and has little risk of bankruptcy at the moment.
  • SURG has a Altman-Z score of 18.18. This is in the better half of the industry: SURG outperforms 70.64% of its industry peers.
  • SURG has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.00, SURG perfoms like the industry average, outperforming 58.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.18
ROIC/WACCN/A
WACCN/A
SURG.CA Yearly LT Debt VS Equity VS FCFSURG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 4.61 indicates that SURG has no problem at all paying its short term obligations.
  • SURG has a Current ratio of 4.61. This is in the better half of the industry: SURG outperforms 71.62% of its industry peers.
  • SURG has a Quick Ratio of 4.61. This indicates that SURG is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.61, SURG is in the better half of the industry, outperforming 72.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.61
Quick Ratio 4.61
SURG.CA Yearly Current Assets VS Current LiabilitesSURG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

0

3. Growth

3.1 Past

  • SURG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.37%, which is quite good.
EPS 1Y (TTM)9.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SURG.CA Yearly EPS VS EstimatesSURG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 -0.02 -0.04 -0.06

0

4. Valuation

4.1 Price/Earnings Ratio

  • SURG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SURG.CA Price Earnings VS Forward Price EarningsSURG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SURG.CA Per share dataSURG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for SURG!.
Industry RankSector Rank
Dividend Yield 0%

SURGE COPPER CORP

TSX-V:SURG (2/4/2026, 7:00:00 PM)

0.55

-0.05 (-8.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-14
Earnings (Next)02-18
Inst Owners2.51%
Inst Owner ChangeN/A
Ins Owners9.69%
Ins Owner ChangeN/A
Market Cap189.98M
Revenue(TTM)N/A
Net Income(TTM)-2.54M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.08
P/tB 3.08
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.18
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.76%
ROE -4.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.72%
ROA(5y)-7.73%
ROE(3y)-4.12%
ROE(5y)-8.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17093.7%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.61
Quick Ratio 4.61
Altman-Z 18.18
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)12368.4%
Cap/Depr(5y)12338.5%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-9.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.67%
OCF growth 3YN/A
OCF growth 5YN/A

SURGE COPPER CORP / SURG.CA FAQ

Can you provide the ChartMill fundamental rating for SURGE COPPER CORP?

ChartMill assigns a fundamental rating of 2 / 10 to SURG.CA.


Can you provide the valuation status for SURGE COPPER CORP?

ChartMill assigns a valuation rating of 0 / 10 to SURGE COPPER CORP (SURG.CA). This can be considered as Overvalued.


What is the profitability of SURG stock?

SURGE COPPER CORP (SURG.CA) has a profitability rating of 1 / 10.